CFO
ZBH icon

CVA Family Office’s Zimmer Biomet ZBH Stock Holding History

CVA Family Office’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
207
+57
+38% +$5K ﹤0.01% 853
2026
Q1 		$13.6K Buy
150
+90
+150% +$8.26K ﹤0.01% 902
2025
Q4 		$5.39K Sell
60
-89
-60% -$8.44K ﹤0.01% 878
2025
Q3 		$14.7K Buy
149
+39
+35% +$3.87K ﹤0.01% 749
2025
Q2 		$10K Sell
110
-75
-41% -$7.25K ﹤0.01% 800
2025
Q1 		$20.9K Sell
185
-18
-9% -$1.93K ﹤0.01% 675
2024
Q4 		$21.4K Buy
203
+118
+139% +$12.7K ﹤0.01% 665
2024
Q3 		$9.18K Sell
85
-85
-50% -$9.28K ﹤0.01% 768
2024
Q2 		$18.4K Buy
170
+81
+91% +$9.55K ﹤0.01% 654
2024
Q1 		$11.7K Buy
89
+4
+5% +$500 ﹤0.01% 724
2023
Q4 		$10.3K Buy
+85
New +$9.48K ﹤0.01% 721
2023
Q3 		– Sell
-95
Closed -$13.8K – 987
2023
Q2 		$13.8K Buy
95
+5
+6% +$679 ﹤0.01% 674
2023
Q1 		$11.6K Sell
90
-10
-10% -$1.26K ﹤0.01% 672
2022
Q4 		$12.8K Buy
100
+15
+18% +$1.74K ﹤0.01% 630
2022
Q3 		$9K Sell
85
-160
-65% -$17.6K ﹤0.01% 650
2022
Q2 		$26K Hold
245
– – 0.01% 497
2022
Q1 		$31K Sell
245
-146
-37% -$17.6K 0.01% 492
2021
Q4 		$48K Buy
+391
New +$51.2K 0.01% 370
2021
Q3 		– Sell
-77
Closed -$12K – 908
2021
Q2 		$12K Sell
77
-26
-25% -$4.21K ﹤0.01% 623
2021
Q1 		$16K Buy
+103
New +$16K 0.01% 456

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CVA Family Office's ZBH Position: Q2 2026 in Review

CVA Family Office increased its Zimmer Biomet (ZBH) stake by 38% in Q2 2026, buying an estimated $5K and bringing the position to 207 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #853.

CVA Family Office first reported a position in ZBH in Q1 2021 and has held it in 20 quarters since. The position peaked at $48K in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • CVA Family Office held 207 shares of Zimmer Biomet worth $17.8K as of Q2 2026.
  • CVA Family Office bought 57 Zimmer Biomet shares in Q2 2026, an estimated $5K.
  • Zimmer Biomet made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #853 holding.
  • CVA Family Office first reported a position in Zimmer Biomet in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's Zimmer Biomet position peaked at $48K in Q4 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.